Alexander City, AL1 Active Studies

Peripheral Artery Disease Clinical Trials in Alexander City, AL

Find 1 actively recruiting peripheral artery disease clinical trials in Alexander City, AL. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
7,050
Enrolling

Recruiting Peripheral Artery Disease Studies in Alexander City

About Peripheral Artery Disease Clinical Trials in Alexander City

Peripheral artery disease (PAD) is a circulatory condition where narrowed arteries reduce blood flow to the limbs, especially the legs. Common symptoms include leg pain when walking (claudication). Treatment includes lifestyle changes, medications, and sometimes procedures to improve blood flow.

There are currently 1 peripheral artery disease clinical trials recruiting participants in Alexander City, AL. These studies are seeking a combined 7,050 participants. Research is being sponsored by Regeneron Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.

Peripheral Artery Disease Clinical Trials in Alexander City — FAQ

Are there peripheral artery disease clinical trials in Alexander City?

Yes, there are 1 peripheral artery disease clinical trials currently recruiting in Alexander City, AL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Alexander City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Alexander City research site will contact you about next steps.

Are clinical trials in Alexander City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Alexander City studies also compensate for your time and travel.

What peripheral artery disease treatments are being tested?

The 1 active trials in Alexander City are testing new therapies including novel drugs, biologics, and treatment approaches for peripheral artery disease.

Data updated July 22, 2026 from ClinicalTrials.gov